Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy
Journal of Nuclear Medicine · 2024-11 · 65 (11) · 1666-1671
DOI: 10.2967/jnumed.124.268363 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 03.10.2024. Verfasst von Jeremie Calais und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California. Hauptthemen laut MEDLINE: Antigens, Surface, Glutamate Carboxypeptidase II, Patient Care, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Optimal patient management protocols for metastatic castration-resistant prostate cancer (mCRPC) are poorly defined and even further complexified with new therapy approvals, such as radiopharmaceuticals. The prostate-specific membrane antigen (PSMA)-targeted agent 177Lu vipivotide tetraxetan ([177Lu]Lu-PSMA-617), approved after the phase III VISION study, presents physicians with additional aspects of patient management, including specific adverse event (AE) monitoring and management, as well as radiation safety. Drawing on our experience as VISION study investigators, here we provide guidance on best practices for delivering PSMA-targeted radiopharmaceutical therapy (RPT) to patients with mCRPC. After a comprehensive review of published evidence and guidelines on RPT management in prostate cancer, we identified educational gaps in managing the radiation safety and AEs associated with [177Lu]Lu-PSMA-617. Our results showed that providing sufficient education on AEs (e.g., fatigue and dry mouth) and radiation safety principles is key to effective delivery and management of patient expectations. Patient counseling by health care professionals, across disciplines, is a cornerstone of optimal patient management during PSMA-targeted RPT. Multidisciplinary collaboration is crucial, and physicians must adhere to radiation safety protocols and counsel patients on radiation safety considerations. Treatment with [177Lu]Lu-PSMA-617 is generally well tolerated; however, additional interventions may be required, such as dosing modification, medications, or transfusions. Urinary incontinence can be challenging in the context of radiation safety. Multidisciplinary collaboration between medical oncologists and nuclear medicine teams ensures that patients are monitored and managed safely and efficiently. In clinical practice, the benefit-to-risk ratio should always be evaluated on a case-by-case basis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California.
- Department of Genitourinary Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
- Department of Radiology, Mayo Clinic, Rochester, Minnesota.
- School of Medicine, University of California, Irvine, California.
- Chesapeake Urology Research Associates, Towson, Maryland.
- Department of Radiation Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada; and.
Förderung
- NCI NIH HHS
Zitieren
APA
Calais, J., Morris, M. J., Kendi, A. T., Kalebasty, A. R., Tutrone, R., Anderson, M. J., & Sartor, O. (2024). Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy. Journal of Nuclear Medicine, 65(11), 1666-1671. https://doi.org/10.2967/jnumed.124.268363
Vancouver
Calais J, Morris MJ, Kendi AT, Kalebasty AR, Tutrone R, Anderson MJ, et al. Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy. Journal of Nuclear Medicine. 2024;65(11):1666-1671. doi:10.2967/jnumed.124.268363
BibTeX
@article{Calais2024,
author = {Calais, Jeremie and Morris, Michael J and Kendi, Ayse Tuba and Kalebasty, Arash Rezazadeh and Tutrone, Ronald and Anderson, Michael J and Sartor, Oliver},
title = {Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy},
journal = {Journal of Nuclear Medicine},
year = {2024},
volume = {65},
number = {11},
pages = {1666--1671},
doi = {10.2967/jnumed.124.268363}
}
EUVIMED